SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050497
Filing Date
2020-11-04
Accepted
2020-11-04 16:19:26
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20200930.htm   iXBRL 10-Q 3448004
2 EX-10.2 ubx-ex102_78.htm EX-10.2 98587
3 EX-10.3 ubx-ex103_34.htm EX-10.3 112886
4 EX-31.1 ubx-ex311_6.htm EX-31.1 19929
5 EX-31.2 ubx-ex312_9.htm EX-31.2 19847
6 EX-32.1 ubx-ex321_8.htm EX-32.1 14578
  Complete submission text file 0001564590-20-050497.txt   11331657

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ubx-20200930.xsd EX-101.SCH 63174
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20200930_cal.xml EX-101.CAL 57844
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20200930_def.xml EX-101.DEF 206236
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20200930_lab.xml EX-101.LAB 482451
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20200930_pre.xml EX-101.PRE 375119
12 EXTRACTED XBRL INSTANCE DOCUMENT ubx-10q_20200930_htm.xml XML 2229522
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 201286955
SIC: 2834 Pharmaceutical Preparations